Scancell plans Neuphoria merger; AstraZeneca wins EU nod for cancer drug

July 23, 2026 10:47 AM EDT News Briefing Scan­cell merges with Ne­upho­ria af­ter Mer­ck ax­es tri­al; As­traZeneca breast can­cer drug ap­proved in EU ENDPOINTS Scan­cell to merge in­to Ne­upho­ria: Scan­cell plans to take over Ne­upho­ria Ther­a­peu­tics’ Nas­daq list­ing $NE­UP and change the tick­er to SCLT … Sign up to read this article for free. Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox. SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER